In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs).

We have previously shown that PFOA and PFOS directly suppress cytokine secretion in immune cells, with different mechanisms of action. In particular, we have demonstrated a role for PPAR-α in PFOA-induced immunotoxicity, and that PFOS has an inhibitory effect on LPS-induced I-κB degradation. These studies investigate the immunomodulatory effects of four other PFCs, namely PFBS, PFOSA, PFDA, and fluorotelomer using in vitro assays. The release of the pro-inflammatory cytokines IL-6 and TNF-α was evaluated in lipolysaccharide (LPS)-stimulated human peripheral blood leukocytes (hPBL) and in the human promyelocytic cell line THP-1, while the release of IL-10 and IFN-γ was evaluated in phytohemagglutinin (PHA)-stimulated hPBL. All PFCs suppressed LPS-induced TNF-α production in hPBL and THP-1 cells, while IL-6 production was suppressed by PFOSA, PFOS, PFDA and fluorotelomer. PFBS, PFOSA, PFOS, PFDA and fluorotelomer inhibited PHA-induced IL-10 release, while IFN-γ secretion was affected by PFOSA, PFOS, PFDA and fluorotelomer. Leukocytes obtained from female donors appear to be more sensitive to the in vitro immunotoxic effects of PFCs when their responses are compared to the results obtained using leukocytes from male donors. Mechanistic investigations demonstrated that inhibition of TNF-α release in THP-1 cells occurred at the transcriptional level. All PFCs, including PFOA and PFOS, decreased LPS-induced NF-κB activation. With the exception of PFOA, none of the PFCs tested was able to activate PPARα driven transcription in transiently transfected THP-1 cells, excluding a role for PPARα in the immunomodulation observed. PFBS and PFDA prevented LPS-induced I-κB degradation. Overall, these studies suggest that PFCs affect NF-κB activation, which directly suppresses cytokine secretion by immune cells. Our results indicate that PFOA is the least active of the PFCs examined followed by PFBS, PFDA, PFOS, PFOSA and fluorotelomer.

[1]  Sierra Rayne,et al.  Perfluoroalkyl sulfonic and carboxylic acids: A critical review of physicochemical properties, levels and patterns in waters and wastewaters, and treatment methods , 2009, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[2]  D. Keil,et al.  Suppression of Humoral Immunity Following Exposure to the Perfluorinated Insecticide Sulfluramid , 2007, Journal of toxicology and environmental health. Part A.

[3]  F. Mach,et al.  Anti-inflammatory properties of statins. , 2004, Seminars in vascular medicine.

[4]  Wenyue Hu,et al.  Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  K P Lee,et al.  Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. , 1987, Experimental and molecular pathology.

[6]  M. Merville,et al.  Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation , 2005 .

[7]  B. Staels,et al.  Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation , 2000, Inflammation Research.

[8]  D. Savitz,et al.  Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA) , 2010, Environmental health perspectives.

[9]  D. Knapen,et al.  Structure-activity relationship assessment of four perfluorinated chemicals using a prolonged zebrafish early life stage test. , 2011, Chemosphere.

[10]  G. Haegeman,et al.  Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1) , 2003, The EMBO journal.

[11]  Mark J. Strynar,et al.  Perfluorooctanoic Acid–Induced Immunomodulation in Adult C57BL/6J or C57BL/6N Female Mice , 2008, Environmental health perspectives.

[12]  Hermann Fromme,et al.  Perfluorinated compounds--exposure assessment for the general population in Western countries. , 2009, International journal of hygiene and environmental health.

[13]  R. G. York,et al.  A two-generation oral gavage reproduction study with potassium perfluorobutanesulfonate (K+PFBS) in Sprague Dawley rats. , 2009, Toxicology.

[14]  B. Abbott,et al.  Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors ( , / , ) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate , 2006 .

[15]  Qiang Yang,et al.  Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. , 2001, Biochemical pharmacology.

[16]  M E Hurtt,et al.  Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  A. Calafat,et al.  Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. , 2011, Environmental science & technology.

[18]  Qian Yang,et al.  Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. , 2002, International immunopharmacology.

[19]  M E Hurtt,et al.  Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[20]  T. Fletcher,et al.  The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. , 2011, Environmental research.

[21]  Roger G Perkins,et al.  The Toxicology of Perfluorooctanoate , 2004, Critical reviews in toxicology.

[22]  J. M. Keller,et al.  Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  J. Anrather,et al.  Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. , 1997, Journal of immunology.

[24]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[25]  Scott A Mabury,et al.  Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss) , 2003, Environmental toxicology and chemistry.

[26]  Qian Yang,et al.  Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. , 2002, Biochemical pharmacology.

[27]  J. M. Keller,et al.  Immunotoxicity of Perfluorinated Compounds: Recent Developments , 2012, Toxicologic pathology.

[28]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[29]  W. V. Berghe,et al.  Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit , 2002 .

[30]  Raymond Liu,et al.  The Direct Effect of Hepatic Peroxisome Proliferators on Rat Leydig Cell Function in Vitro1 , 1996 .

[31]  L. Shaw,et al.  Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters , 2006, Journal of occupational and environmental medicine.

[32]  M. Schmitz,et al.  I?B-independent control of NF-?B activity by modulatory phosphorylations , 2001 .

[33]  Jiayin Dai,et al.  Perfluorononanoic acid induces apoptosis involving the Fas death receptor signaling pathway in rat testis. , 2009, Toxicology letters.

[34]  J. Mandel,et al.  Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. , 1999, Journal of occupational and environmental medicine.

[35]  Marina Marinovich,et al.  In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). , 2011, Toxicology and applied pharmacology.

[36]  Jeffrey H Mandel,et al.  Characterization of risk for general population exposure to perfluorooctanoate. , 2004, Regulatory toxicology and pharmacology : RTP.

[37]  J. Depierre,et al.  The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). , 2009, Toxicology.

[38]  A. A. Jensen,et al.  Do Perfluoroalkyl Compounds Impair Human Semen Quality? , 2009, Environmental health perspectives.

[39]  N. Yamashita,et al.  Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. , 2009, The Journal of toxicological sciences.

[40]  John W. Froehlich,et al.  Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.

[41]  Kyungho Choi,et al.  Toxicity of perfluorooctane sulfonic acid and perfluorooctanoic acid on freshwater macroinvertebrates (Daphnia magna and Moina macrocopa) and fish (Oryzias latipes) , 2008, Environmental toxicology and chemistry.

[42]  G. Crabtree,et al.  Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.

[43]  D. Consonni,et al.  Thirty Years of Medical Surveillance in Perfluooctanoic Acid Production Workers , 2009, Journal of occupational and environmental medicine.

[44]  L. S. Haug,et al.  Characterisation of human exposure pathways to perfluorinated compounds--comparing exposure estimates with biomarkers of exposure. , 2011, Environment International.

[45]  A. Calafat,et al.  Human exposure assessment to environmental chemicals using biomonitoring. , 2006, International journal of andrology.

[46]  Fatihah Suja,et al.  Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper. , 2009, Water science and technology : a journal of the International Association on Water Pollution Research.

[47]  C. Lau,et al.  The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.

[48]  R. Luebke,et al.  Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.